About the offering
Gatlan by Immortal Male, Inc. (branded as 'Gatlan') is a provider-led, consumer telehealth platform headquartered in Plano, TX, founded by actor Josh Duhamel. The company offers personalized performance and longevity-focused care—including hormone replacement therapy (HRT/TRT), weight optimization, and anti-aging treatments—delivered through a network of licensed medical professionals via a concierge telehealth model. The platform is designed to make proactive, medically supervised care more accessible, stigma-free, and personalized compared to traditional healthcare systems. Key business metrics cited include an average order value of over $450 since inception, a paid customer acquisition cost of approximately $250, and an all-in acquisition cost below $100 when factoring in owned and earned media. Repeat rates in 2025 were reported at over 80% for TRT patients and 60% for all other products. The platform expanded into women's health and launched an expanded platform in March 2026, with monthly revenue reportedly growing each month since. The company targets the broader longevity and performance health market, citing the U.S. hormone replacement market at $11.6B in 2024 (projected to reach $19.2B by 2033) and the U.S. anti-aging Rx market at $10B+ in 2024 (projected to reach $25B+ by 2035). The leadership team includes CEO Tyler Williamson, a former military officer with executive experience at Beats by Dre (pre-Apple acquisition), Apple, PepsiCo, and Kraft Foods, who currently draws no salary from Gatlan. Board members include Josh Duhamel (founder) and Fabian Calvo, a pharmaceutical executive with expertise in API supply chains and regulatory compliance. The company has received media coverage through outlets and podcasts including Megyn Kelly, Fox News, Forbes, Piers Morgan, Chris Cuomo, The Ed Mylett Show, and others. The long-term vision includes building a broader performance and longevity ecosystem powered by AI and advanced data. The offering is structured as a Crowdfunding SAFE (Simple Agreement for Future Equity) with a $25M valuation cap and a 10% base discount, with a minimum investment of $500 and a conversion trigger of $1,000,000 in a qualified equity financing. Various investment perks including treatment discounts and virtual/in-person investor events are offered at tiered investment levels.
FAQ
How much has Gatlan raised?
Gatlan has raised $0 of a $1.24M goal.
Where is Gatlan's campaign live?
The offering is live on StartEngine, an SEC-registered Reg CF intermediary.
What are the terms of Gatlan's raise?
Other, $25M cap, 10% discount.
When does Gatlan's offering close?
The stated close date is Dec 23, 2026.